Tempus AI (NASDAQ:TEM) Shares Up 3.8% – Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM) traded up 3.8% during mid-day trading on Thursday . The stock traded as high as $35.29 and last traded at $35.05. 1,233,969 shares changed hands during trading, a decline of 25% from the average session volume of 1,636,523 shares. The stock had previously closed at $33.76.

Analyst Ratings Changes

Several research analysts have weighed in on TEM shares. Wolfe Research started coverage on shares of Tempus AI in a research report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target on the stock. Guggenheim assumed coverage on Tempus AI in a report on Monday, December 9th. They issued a “buy” rating and a $74.00 target price on the stock. Piper Sandler reissued a “neutral” rating and set a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Bank of America raised their price objective on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Finally, Loop Capital lifted their price objective on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and an average price target of $56.00.

Tempus AI Stock Performance

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The stock has a fifty day moving average of $48.93 and a 200 day moving average of $46.63.

Insider Transactions at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the firm’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the transaction, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This trade represents a 2.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Andrew Polovin sold 51,504 shares of the company’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the sale, the executive vice president now directly owns 246,085 shares in the company, valued at approximately $10,431,543.15. The trade was a 17.31 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 845,041 shares of company stock valued at $35,125,473.

Institutional Trading of Tempus AI

A number of large investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. bought a new position in Tempus AI in the third quarter worth approximately $30,000. Vestor Capital LLC bought a new position in shares of Tempus AI during the 3rd quarter worth $153,000. Stifel Financial Corp purchased a new position in shares of Tempus AI during the third quarter valued at $218,000. Sandia Investment Management LP bought a new stake in shares of Tempus AI in the second quarter valued at about $136,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new stake in Tempus AI in the third quarter worth about $258,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.